Motivational interviewing for male couples to reduce drug use and HIV risk
Official title: Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples
Run by Hunter College of City University of New York · NCT06307977 · Data updated 2026-11-12
This study is testing whether a special conversation technique for male couples can help reduce drug use and lower the risk of HIV.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 55 Years |
| Sex | Men only |
| Enrollment | 360 (estimated) |
| Sponsor | Hunter College of City University of New York Academic / other |
| Locations | 3 sites (Detroit, Michigan and 2 other locations) |
| Status | Recruiting |
| Started | May 25, 2024 |
| Main results expected | January 2028 |
| Study ends | February 2029 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT06307977 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are male couples where one partner is HIV negative and both have a history of drug use and HIV risk behaviors.
✕Probably not a fit
Patients who are not in a male couple relationship or those without recent drug use or HIV risk behaviors may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of couples motivational interviewing (MI) in reducing illicit drug use and HIV transmission risk behaviors among male couples. Participants are randomly assigned to either receive couples MI or standard couples HIV testing and counseling. The study aims to assess changes in drug use frequency and HIV risk behaviors over time. By focusing on couples, the intervention seeks to leverage relationship dynamics to promote healthier behaviors.
Why it matters
Potential benefit: If successful, this approach could significantly lower drug use and HIV transmission rates among vulnerable male couples.
How similar studies have gone: Other studies have shown promise in using motivational interviewing for substance use and HIV risk reduction, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have a main partner who is another cisgender male and have been in a relationship for 3 month or longer * Index participant must be between 18 and 55; Main partner can be any age 18 and older * One participant must be HIV negative (as confirmed by rapid test) * One participant must have used at least 1 drug in the past 30 days (cocaine/crack, opiates, misuse of prescription medication, stimulants, psychedelics, ecstasy, ketamine, GHB, amyl nitrite) * Index participant must have engaged in TRB in the past 30 days- Defined as CAS with a casual partner, or a serodiscordant or non-monogamous main partner * Live in the United States * Speak and read English Exclusion Criteria * Any signs of serious mental illness or cognitive deficit * Current suicidal/homicidal ideations * History of IPV with their main partner and safety concerns in the current relationship.
Where it's running
-
Hunter College
New York, New York, United States Recruiting -
Wayne State University
Detroit, Michigan, United States Active not recruiting -
University of Virginia
Charlottesville, Virginia, United States Active not recruiting
Study contacts
- Study coordinator: Tyrel J Starks, PHD
- Email: tstarks@hunter.cuny.edu
- Phone: 212-206-7919
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Peer support to improve HIV treatment adherence in high-risk populations
This study is testing whether a peer support program can help Black individuals who use substances and are living with or at high risk for HIV stick to their long-acting injectable treatments better than standard care.
-
Peer support program to improve health for women living with HIV
This study tests a program that combines therapy, exercise, and support from peers to help women living with HIV stick to their medications and improve their overall health.
-
Camino HIV Prevention and Care Study
This study tests a combined legal and peer-support program to help Latin American adults in DC and the Bay Area improve HIV testing, PrEP use, and care engagement.
-
VH4367310 in healthy adults: testing single increasing doses for safety and how it behaves in the body
This study tests a single rising dose of VH4367310, a cabotegravir prodrug, to see how it behaves in the body and how safe and tolerable it is in healthy adults aged 18 to 55.
-
Online cohort of sexual and gender minorities testing digital support to boost PrEP and ART use
In Brazil, sexually and gender diverse adults are being followed online to see if weekly WhatsApp reminders help people stick to PrEP or ART.
-
Metabolic Liver Disease in People Newly Diagnosed with HIV
This study tests whether HIV-infected adults who are starting ART are more likely to develop MASLD and related liver issues than HIV-negative adults over five years.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.